Literature DB >> 14884260

Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.

A B GUTMAN, T F YU.   

Abstract

Entities:  

Keywords:  GOUT/therapy; URIC ACID/in urine

Mesh：

Substances：

Year:  1951        PMID： 14884260

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  9 in total

1.  Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Authors:  T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

Authors:  T F YUE; P G DAYTON; A B GUTMAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

3.  Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents.

Authors:  A B GUTMAN; T F YU
Journal:  Bull N Y Acad Med       Date:  1958-05

4.  Rheumatology practice at Mayo Clinic: the first 40 years-1920 to 1960.

Authors:  Gene G Hunder; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

5.  Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.

Authors:  J H SIROTA; T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1952-07       Impact factor: 14.808

6.  Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance.

Authors:  Jack Rubinstein; Valerie M Lasko; Sheryl E Koch; Vivek P Singh; Vinicius Carreira; Nathan Robbins; Amit R Patel; Min Jiang; Philip Bidwell; Evangelia G Kranias; W Keith Jones; John N Lorenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

Review 7.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

8.  Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation.

Authors:  Sheryl E Koch; Xiaoqian Gao; Lauren Haar; Min Jiang; Valerie M Lasko; Nathan Robbins; Wenfeng Cai; Cole Brokamp; Priyanka Varma; Michael Tranter; Yong Liu; Xiaoping Ren; John N Lorenz; Hong-Sheng Wang; W Keith Jones; Jack Rubinstein
Journal:  J Mol Cell Cardiol       Date:  2012-04-27       Impact factor: 5.000

Review 9.  Gout: An old disease in new perspective - A review.

Authors:  Gaafar Ragab; Mohsen Elshahaly; Thomas Bardin
Journal:  J Adv Res       Date:  2017-05-10       Impact factor: 10.479
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.